Includes all AIM, ASX, CBOE, CSE, LSE, TSX and TSXV companies with US symbols
Loading...
Get Featured
Pink

DOSEFDoseology Sciences Inc.

Loading price...
Loading price changes...
Loading market cap...

Price Chart

Loading chart...

About Doseology Sciences Inc. (DOSEF)

Doseology Sciences Inc. (DOSEF) is a Biotechnology company headquartered in Kelowna, BC, Canada whose shares trade over-the-counter on the Pink tier.

Doseology Sciences Inc. is building a progressive brand focused on mental health and wellness through innovative nutraceutical products. Doseology aims to make a meaningful impact on the mental health pandemic by utilizing and developing functional fungi and plant-derived drugs. Doseology's functional mushroom products, including tinctures, powders and supplements, are available on doseology.com.

Products and services

The Company has developed a functional mushroom brand with products that are focused on the health and wellness markets. The Company has launched its product line of proprietary functional mushroom tinctures, a powder, and capsules in Canada and the United States. The Company's products are carefully crafted with Reishi, Lion’s Mane, Cordycep or Shiitake and blended with select adaptogens like ginger, chamomile, yerba mate and turmeric. These blended formulations deliver enhanced health and wellness benefits over single-ingredient products. Each product is formulated and positioned to compete in both the medicinal mushroom and nootropics markets, and each addresses different market needs, including mood, energy, recovery, sleep and focus. The Company sells its functional mushroom products directly to consumers, to e-tailers and to retailers.

DOSEF key facts

Ticker symbol
DOSEF
Market tier
Pink
Headquarters
Kelowna, BC, Canada
Country of incorporation
CA
Year of incorporation
2019
Employees
3
Estimated market cap
$427.5K (as of May 9, 2025)
Shares outstanding
4,500,515
Reporting standard
International Reporting: Canadian Securities Exchange
Audit status
Audited
Fiscal year end
6/30
Latest filing
Quarterly Report (Mar 31, 2024)

Doseology Sciences Inc. leadership

  • Shawn Balaghi — Acting CEO
  • Christopher Cherry — CFO
  • Lindsay Megan Allyssa Hamelin — Corporate Secretary

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with D

Press Releases

Loading press releases...

Latest News

Loading news...

SPONSORED
Loading ads...
SPONSORED
Loading ads...

Key Statistics

Major Holders

Loading...

Loading modules...

AI-Powered Stock Analysis

Get a concise 600-word investment analysis for Doseology Sciences Inc. (DOSEF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.

Still in beta - Please send feedback after generating your analysis to help us improve!

Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!

By submitting, you agree to our Privacy Policy and Terms of Service. We'll add you to our newsletter but you can unsubscribe at any time.

Investor Reviews

Investor Reviews (0)

Loading reviews...

Get Verified

Is this your company?

Get verified and take control of your company page. Add your verified badge, edit information, and showcase your business to investors.

Low Cost
Quick Setup
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...

Company Profile

Loading company profile data...

Contact Information

Fax
Not provided
Investor Relations Email
Not provided
Headquarters Address
Suite 305, 9–3151 Lakeshore Rd.
Kelowna, BC, V1W 3S9
Canada

Company Leadership

Company Officers

Shawn Balaghi
Acting CEO
Christopher Cherry
CFO
Lindsay Megan Allyssa Hamelin
Corporate Secretary

Social Media

Business Details

Stock Details

Loading modules...